Laura Dillon

Laura Dillon

Company: Parthenon Therapeutics

Job title: Head of Translational Biomarkers


Characterization of Immune Excluded Tumors by Multiplex Immunofluorescence for Precision Oncology applications 11:00 am

• Understanding how the spatial relationship between immune cells and the tumor epithelium vs tumor associated stroma is key to reviewing immune exclusion and its relationship to CPI therapy resistance • Thoughtful mIF panel design and reagent validation are necessary to enable interpretation of mIF output • Novel methods are needed to better characterize the…Read more

day: Conference Agenda

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.